News

The Faltas Lab was awarded Memorial Sloan Kettering Cancer Center’s Bladder SPORE Developmental Research Program to study “Targeted strategies for enhancing anti-tumor immunity in immunocompetent bladder cancer mouse models.”

Dr. Faltas’s study was selected by the SCC Executive Committee as part of the Twelfth Starr Cancer Consortium Grant Competition. The grant will provide $840,000 over two years.

“This generous support from the Starr Cancer Consortium will enable our team to investigate how APOBEC3-mutagenesis shapes the bladder cancer genome especially in critical forms of genomic instability such as chromothripsis. We hope to translate the knowledge we gain from our laboratory experiments into new...

The Faltas lab was awarded a pilot grant to dissect role of co-occuring FGFR and cell cycle genomic alterations in sensitivity of urothelial carcinoma to combined FGFR-and CDK4/6-inhibition. This funding from the Functional Genomics Initiative co-adminstered with the Englander Institute for Precision Medicine will enable us to pursue a new direction of research. Based on our improved understanding of the molecular changes that drive bladder cancer, we have identified two pathways that are...

Check out our X feeds for the lastest news.

Weill Cornell Medicine Faltas Lab 1300 York Avenue, 6th Floor New York, NY 10022 Phone: 646-962-2072